Elabela vs Urocortin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Elabela (also called Apela or Toddler) is the second endogenous peptide ligand for the APJ receptor, discovered in 2013 independently through two approaches: as an essential zebrafish cardiac development factor (Toddler) and as a novel human APJ ligand (Elabela). Unlike apelin pe...
Calculate Elabela dose →Urocortin 1 (UCN1) is a 40-amino acid peptide belonging to the corticotropin-releasing factor (CRF) family. While sharing structural homology with CRF, UCN1 binds with higher affinity to CRF receptor type 2 (CRFR2), which predominates in the heart, skeletal muscle, and peripheral...
Calculate Urocortin dose →| Parameter | Elabela | Urocortin |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Research | Clinical |
| Half-Life | Short (minutes, estimated) | 1-3 hours |
| Typical Dose | 5-500 nmol/kg (animal) | 0.5-10 pmol/kg/min (IV infusion) |
| Frequency | Variable | Acute infusion or short courses |
| Route | Subcutaneous, Intravenous | Intravenous, Subcutaneous |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.